156001-68-2

Basic information

• Product Name: methyl 3-cyano-4-hydroxybenzoate
• Synonyms: methyl 3-cyano-4-hydroxybenzoate;3-Cyano-4-hydroxybenzoic acid methyl ester
• CAS NO: 156001-68-2
• Molecular Formula: C₉H₇NO₃
• Molecular Weight: 177.158
• Mol File: 156001-68-2.mol
• Article Data: 23

Chemical Properties

• Melting Point: 167-168 °C(Solv: methanol (67-56-1); water (7732-18-5))
• Boiling Point: 336.305 °C at 760 mmHg
• Flash Point: 157.192 °C
• Appearance: /
• Density: 1.328 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.573
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 5.56±0.18(Predicted)
• CAS DataBase Reference: methyl 3-cyano-4-hydroxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-cyano-4-hydroxybenzoate(156001-68-2)
• EPA Substance Registry System: methyl 3-cyano-4-hydroxybenzoate(156001-68-2)

Safety Data

• Hazardous Substances Data: 156001-68-2(Hazardous Substances Data)

Usage

General Description

Methyl 3-cyano-4-hydroxybenzoate is an organic compound, specifically an aromatic ester that contains a benzoic acid (or benzene carboxylic acid) group. The prefix 'methyl' indicates the presence of a methyl group (-CH3) in the chemical structure, 'cyano' points towards a cyanide (-C≡N) group and 'hydroxy' is indicative of a hydroxyl (-OH) group. Therefore, the compound houses a benzene ring which is substituted by a -COOCH3 (methyl ester), -CN (cyano), and -OH (hydroxy) groups. Considering its composition and structure, it is likely to exist as a white or off-white solid, but specific properties would depend on its purity form. The applications of this compound are unstated and it is quite possible that it is used in chemical research or as an intermediate in the synthesis of other more complex molecules.

InChI:InChI=1/C9H7NO3/c1-13-9(12)6-2-3-8(11)7(4-6)5-10/h2-4,11H,1H3

Upstream product

• 15126-06-4 methyl 3-iodo-4-hydroxybenzoate 
• 143-33-9 sodium cyanide 
• 544-92-3 copper(I) cyanide 
• 557-21-1 zinc(II) cyanide 
• 773837-37-9 sodium cyanide 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 24589-99-9 methyl 3-formyl-4-hydroxybenzoate 
• 584-87-2 3-formyl-4-hydroxybenzoic acid 
• 99-76-3 methyl 4-hydroxylbenzoate 

Downstream Products

• 609804-40-2 2-(4-Methoxycarbonyl-2-cyanophenoxy)-N-(5-chloropyridin-2-yl)acetamide 
• 213598-11-9 methyl 3-cyano-4-[(1-methylethyl)oxy]benzoate 
• 1192829-78-9 methyl 3-cyano-4-(cyclopropylmethoxy)benzoate 
• 25978-74-9 3-Cyano-4-methoxy-benzoic acid methyl ester 
• 156001-69-3 methyl 3-cyano-4-(((trifluoromethyl)sulfonyl)oxy)benzoate 
• 288251-99-0 3-cyano-4-(2-methylpropyl)benzoic acid 
• 1034689-19-4 methyl 3-cyano-4-(2-methylpropyl)benzoate 
• 1258440-90-2 5-(5-amino-1,3,4-thiadiazol-2-yl)-2-(2-methylpropyl)benzonitrile 
• 1344995-82-9 1-[2-(3-{5-[3-cyano-4-(2-methylpropyl)phenyl]-1,3,4-thiadiazol-2-yl}-2-ethylphenyl)ethyl]-3-azetidinecarboxylic acid 
• 1344995-84-1 1-[2-(3-{5-[3-cyano-4-(2-methylpropyl)phenyl]-1,3,4-thiadiazol-2-yl}-2-ethylphenyl)ethyl]-4-piperidinecarboxylic acid 
• 1344995-93-2 1-{2-[3-{5-[3-cyano-4-(2-methylpropyl)phenyl]-1,3,4-thiadiazol-2-yl}-5-fluoro-2-(methyloxy)phenyl]ethyl}-3-azetidinecarboxylic acid 
• 1344996-58-2 1-[(3-{5-[3-cyano-4-(2-methylpropyl)phenyl]-1,3,4-thiadiazol-2-yl}-2-ethylphenyl)methyl]-3-pyrrolidinecarboxylic acid 
• 1344996-75-3 1-[2-(3-{5-[3-cyano-4-(2-methylpropyl)phenyl]-1,3,4-thiadiazol-2-yl}-2-ethylphenyl)ethyl]-L-proline 
• 1344997-41-6 5-[5-(2-ethyl-3-formylphenyl)-1,3,4-thiadiazol-2-yl]-2-(2-methylpropyl)benzonitrile 

Relevant articles and documents

AMINO ALCOHOL DERIVATIVE, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

The present invention belongs to the field of medicine, and specifically discloses an amino alcohol derivative represented by Formula I, a pharmaceutically acceptable salt, solvate, polymorph or prodrug thereof. In addition, the present invention also discloses a pharmaceutical composition comprising the above substances, and a use of the substance in the preparation of a medicament for the prevention and treatment of an immune inflammatory disease, or a disease or condition associated with immunological competence such as multiple sclerosis, ALS, CIDP, systemic lupus erythematosus, rheumatoid arthritis, ulcerative colitis, psoriasis, polymyositis, etc.

INHIBITORS OF LOW MOLECULAR WEIGHT PROTEIN TYROSINE PHOSPHATASE (LMPTP) AND USES THEREOF

Protein tyrosine phosphatases (PTPs) are key regulators of metabolism and insulin signaling. As a negative regulator of insulin signaling, the low molecular weight protein tyrosine phosphatase (LMPTP) is a target for insulin resistance and related conditions. Described herein are compounds capable of modulating the level of activity of low molecular weight protein tyrosine phosphatase (LMPTP) and compositions, and methods of using these compounds and compositions.

Preparation method of 3-cyano-4-isopropoxy methyl benzoate

The invention discloses a preparation method of 3-cyano-4-isopropoxy methyl benzoate. The preparation method comprises the following steps: step I, preparing 3-aldehyde-4-methyl hydroxybenzoate from methyl p-hydroxybenzoate; step II, preparing 3-cyano-4-m